3D Global Biotech Inc. (TPEX:6808)
Taiwan · Delayed Price · Currency is TWD 30.65
-0.35 (-1.13%)
May 8, 2026, 1:48 PM CST
3D Global Biotech Market Cap
3D Global Biotech has a market cap or net worth of 2.39 billion as of May 8, 2026. Its market cap has decreased by -39.93% in one year.
Market Cap
2.39B
Enterprise Value
1.97B
Revenue
206.74M
Ranking
n/a
PE Ratio
37.02
Stock Price
30.65
Market Cap Chart
Since December 25, 2020, 3D Global Biotech's market cap has decreased from 2.74B to 2.39B, a decrease of -12.50%. That is a compound annual growth rate of -2.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 2.39B | -36.32% |
| Dec 31, 2025 | 3.76B | -26.72% |
| Dec 31, 2024 | 5.13B | 371.49% |
| Dec 29, 2023 | 1.09B | -27.35% |
| Dec 30, 2022 | 1.50B | -30.09% |
| Dec 30, 2021 | 2.14B | -18.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 25, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chunghwa Chemical Synthesis & Biotech | 2.98B |
| HeXun Biosciences | 2.85B |
| Apex Biotechnology | 2.83B |
| Syngen Biotech | 2.69B |
| Sunhawk Vision Biotech | 2.61B |
| GlycoNex Incorporation | 2.43B |
| Sunny Pharmtech | 2.21B |
| G&E Herbal Biotechnology | 2.19B |